FDA.reportPublic FDA data

Application 219531

Type
NDA
Sponsor
BRILLIAN PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SDAMLOAMLODIPINE BESYLATEFOR SOLUTION;ORALEQ 2.5MG BASE/BOTYesYes
002SDAMLOAMLODIPINE BESYLATEFOR SOLUTION;ORALEQ 5MG BASE/BOTYesYes
003SDAMLOAMLODIPINE BESYLATEFOR SOLUTION;ORALEQ 10MG BASE/BOTYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N219531-001SDAMLOAMLODIPINE BESYLATEEQ 2.5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24
N219531-002SDAMLOAMLODIPINE BESYLATEEQ 5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24
N219531-003SDAMLOAMLODIPINE BESYLATEEQ 10MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N219531-001SDAMLOEQ 2.5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-2484e616aacf4f…
2026-09-14 22:38:342026-08N219531-002SDAMLOEQ 5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-2484e616aacf4f…
2026-09-14 22:38:342026-08N219531-003SDAMLOEQ 10MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-2484e616aacf4f…
2026-08-18 06:07:402026-07N219531-001SDAMLOEQ 2.5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24caaa826d4ba7…
2026-08-18 06:07:402026-07N219531-002SDAMLOEQ 5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24caaa826d4ba7…
2026-08-18 06:07:402026-07N219531-003SDAMLOEQ 10MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N219531-001SDAMLOEQ 2.5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N219531-002SDAMLOEQ 5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N219531-003SDAMLOEQ 10MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N219531-001SDAMLOEQ 2.5MG BASE/BOTFOR SOLUTION / ORALRLD2025-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N219531-002SDAMLOEQ 5MG BASE/BOTFOR SOLUTION / ORALRLD2025-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N219531-003SDAMLOEQ 10MG BASE/BOTFOR SOLUTION / ORALRLD2025-07-2431067a03dcf5…
2025-08-23 18:47 UTC2025-08N219531-001SDAMLOEQ 2.5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N219531-002SDAMLOEQ 5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N219531-003SDAMLOEQ 10MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-246a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N219531-001SDAMLOEQ 2.5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N219531-002SDAMLOEQ 5MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N219531-003SDAMLOEQ 10MG BASE/BOTFOR SOLUTION / ORALRLD, RS2025-07-24a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 7 · 126 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AMLODIPINE BESYLATEAMLODIPINE BESYLATEBryant Ranch Prepack215e0890-0484-45e8-a731-aea53821ad8e2026-05-19Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATECoupler LLC2904c6e1-2c51-8035-e063-6294a90aa04b2026-05-13Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATEPD-Rx Pharmaceuticals, Inc.5a0b3dd4-91f5-4173-a992-e91b1cac6a182026-05-05Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATEBryant Ranch Prepack72dafc2f-5266-442b-914a-61d1ef1f7ab82026-04-29Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATEREMEDYREPACK INC.d2f66b58-78ec-456b-8397-2120a223827c2026-04-28Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATEA-S Medication Solutionscd305e6e-9107-4d25-9918-8d0d9b9ba1ca2026-04-24Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATEA-S Medication Solutions50204e86-a345-4d2f-b62f-a548787e197f2026-04-24Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATELupin Pharmaceuticals, Inc.003dd1ec-16f8-4f96-b6a8-c4689d35892a2026-04-20Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATEREMEDYREPACK INC.988e5acb-356e-4116-b6db-ab8468ed72342026-04-13Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATECardinal Health 107, LLCa74239bf-4684-424c-ba4e-6087e363265b2026-04-09Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
AMLODIPINE BESYLATE 2.5 mgAMLODIPINE BESYLATEOxford Pharmaceuticals, LLC6f20efca-943b-4bc2-a157-0931bd4d45852026-03-28Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATELegacy Pharmaceutical Packaging, LLC2cdd0da9-eea6-45e0-b0b7-35413a168a4f2026-03-03Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
AMLODIPINE BESYLATEAMLODIPINE BESYLATELegacy Pharmaceutical Packaging, LLC215ef2cb-d5b6-43d5-bbd5-195ec57cde2b2026-03-03Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATEAurobindo Pharma Limitedb6f298ba-2d7e-4a3c-9edb-8b60aba716d62026-03-03Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATEPreferred Pharmaceuticals Inc.1df35c9b-0cd8-41f4-b9d4-8f51ba57b3e02026-02-26Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATEPreferred Pharmaceuticals Inc.a6635bb3-b8d5-4046-ac56-27af9bac877e2026-02-26Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
AMLODIPINE BESYLATEAMLODIPINE BESYLATEPreferred Pharmaceuticals Inc.aec7618e-c9da-431f-8b6a-14aa399242f62026-02-25Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
AMLODIPINE BESYLATE 10 mgAMLODIPINE BESYLATEPreferred Pharmaceuticals Inc.ea9f44a1-96cf-496a-8c07-18d8de27e5122026-02-25Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATEPreferred Pharmaceuticals, Inc.01139e81-a4fa-4e13-acdf-c75c79a1aa9c2026-02-23Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE
Amlodipine BesylateAMLODIPINE BESYLATEPreferred Pharmaceuticals Inc.1ff04bd2-9926-48a4-9afc-eab0789dba012026-02-23Warnings, Adverse reactionsName fallback
generic name: AMLODIPINE BESYLATE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85871SUPPL 2026-05-11
83798ORIG 2025-10-17
82960ORIG 2025-07-28
82942ORIG 2025-07-25